Key Takeaways
- • Bertram Capital acquired Medical Technology Associates (MTA), a Pinellas Park, Florida provider of regulatory compliance services, from Riverarch Equity Partners.
- • MTA is the eighth platform investment in Bertram's Fund V, and its more than 150 technicians serve hospitals, health systems, pharmacies and laboratories.
- • Riverarch, based in Pittsburgh, had acquired MTA in 2022; CEO Allan Morris and the leadership team remain and retain meaningful ownership.
- • Bertram plans to expand technician headcount, service lines and geographic coverage through both organic growth and acquisitions.
- • Houlihan Lokey advised the seller, Intrepid Investment Bankers advised Bertram, and Golub Capital and BTG Pactual Strategic Capital provided financing.
Summary
MTA's more than 150 technicians test, inspect, certify, repair and replace equipment across medical gas, controlled environment, calibration, biomedical and laboratory testing. Its work helps customers meet requirements set by NFPA 99, the Centers for Medicare & Medicaid Services (CMS), the Joint Commission and the United States Pharmacopeia (USP).
Chief Executive Allan Morris and the existing leadership team remain in place and retain meaningful ownership in the business, signaling continuity under the new sponsor. Bertram plans to add technicians, services and geographic coverage, pursuing growth both organically and through further acquisitions.
Houlihan Lokey advised Riverarch on the sale, while Intrepid Investment Bankers advised Bertram. Golub Capital and BTG Pactual Strategic Capital provided financing for the transaction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.